During the current COVID-19 pandemic, Dr Lee, a medical oncologist, created and implemented a national prospective observational cohort study of cancer patients, the UK Coronavirus Cancer Monitoring Project (UK CCMP). The study was the first to identify that cancer treatments could be safely administered during the pandemic, as published in The Lancet.
Dr Lennard Lee said: ‘No one should be denied appropriate cancer treatments and it is important that we continue to deliver research excellence in order to protect the vulnerable during this pandemic.’
Dr Lee also said that he is extremely grateful to OUCAGS for the academic/clinical and mentorship support during his clinical lectureship.
Read more about the ACP McElwain Prize award